In terms of medical history, 79 participants (53%) reported a history of liver cirrhosis, whereas 27 participants reported switching to EBR/GZR treatment after failure to respond to PEG‐IFN plus RBV treatment previously. This evidence concerns the gene IFNA1 and cirrhosis of liver.